Calculi Dissolution Agent [EPC]

Calculi Dissolution Agent [EPC] was reported 1269 times

Drugs of the Calculi Dissolution Agent [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 PES ANSERINUS SYNDROME 1 0.3333
1 IMAGING PROCEDURE ARTIFACT 3 0.1875
2 POSTPOLYPECTOMY SYNDROME 1 0.1667
3 INTRAVASCULAR GAS 1 0.1000
4 NASOGASTRIC OUTPUT HIGH 1 0.0833
5 OCCUPATIONAL EXPOSURE TO SUNLIGHT 1 0.0769
6 OOCYTE HARVEST 1 0.0526
7 LYMPHOID HYPERPLASIA OF INTESTINE 1 0.0455
8 PULMONARY ARTERIAL WEDGE PRESSURE DECREASED 1 0.0400
9 BILE DUCT STENT REMOVAL 1 0.0370
10 FIXED BOWEL LOOP 1 0.0370
11 PROCEDURE ABORTED 1 0.0286
12 OCCUPATIONAL EXPOSURE TO RADIATION 1 0.0286
13 JOINT DEFORMITY 2 0.0267
14 BENIGN SMALL INTESTINAL NEOPLASM 1 0.0256
15 BLOOD GLUCOSE NORMAL 1 0.0250
16 PERCEPTUAL DISTURBANCE 1 0.0227
17 INCISION SITE ULCER 1 0.0208
18 MEDICAL DEVICE SITE FIBROSIS 1 0.0204
19 MAGNESIUM METABOLISM DISORDER 1 0.0204
20 PERICARDIAL CALCIFICATION 1 0.0200
21 MESENTERIC LYMPHADENITIS 1 0.0192
22 DRUG DEPENDENCE, ANTEPARTUM 1 0.0192
23 CLAUDICATION OF JAW MUSCLES 1 0.0167
24 DENTAL PARAESTHESIA 1 0.0164
25 PRODUCT BARCODE ISSUE 6 0.0155
26 ANALGESIC ASTHMA SYNDROME 1 0.0154
27 PRODUCT PACKAGING DIFFICULT TO OPEN 35 0.0134
28 DEVICE TEMPERATURE ISSUE 1 0.0133
29 ANAESTHETIC COMPLICATION PULMONARY 1 0.0112
30 THERAPEUTIC PRODUCT EFFECT PROLONGED 5 0.0110
31 IRON BINDING CAPACITY TOTAL INCREASED 1 0.0108
32 ILEOCOLECTOMY 1 0.0100
33 SALPINGO-OOPHORECTOMY BILATERAL 2 0.0099
34 INTESTINAL CONGESTION 1 0.0096
35 ADHESIOLYSIS 1 0.0093
36 HYPERAMMONAEMIC CRISIS 1 0.0093
37 SHIGELLA INFECTION 1 0.0088
38 CONGENITAL NEUROLOGICAL DISORDER 1 0.0085
39 ANAL ERYTHEMA 1 0.0080
40 GASTROINTESTINAL LYMPHOMA 2 0.0077
41 GENITAL INJURY 1 0.0075
42 FISTULA OF SMALL INTESTINE 3 0.0072
43 MESENTERIC PANNICULITIS 2 0.0067
44 CERVIX CARCINOMA STAGE I 1 0.0065
45 ADNEXA UTERI CYST 1 0.0062
46 ARTHRITIS ENTEROPATHIC 2 0.0061
47 EYELID BLEEDING 1 0.0058
48 POSTPRANDIAL HYPOGLYCAEMIA 1 0.0053
49 PENILE INFECTION 1 0.0052
50 DEAFNESS PERMANENT 1 0.0051
51 PROGRESSIVE SUPRANUCLEAR PALSY 1 0.0050
52 TERMINAL ILEITIS 3 0.0049
53 GREATER TROCHANTERIC PAIN SYNDROME 1 0.0049
54 SALT CRAVING 1 0.0048
55 PRODUCT INTOLERANCE 1 0.0045
56 MUCOCUTANEOUS ULCERATION 1 0.0044
57 NEUROGENIC BOWEL 1 0.0042
58 SALPINGECTOMY 2 0.0035
59 LABELLED DRUG-DRUG INTERACTION ISSUE 5 0.0035
60 BURSA DISORDER 1 0.0034
61 HEART FAILURE WITH PRESERVED EJECTION FRACTION 1 0.0034
62 UPPER AIRWAY OBSTRUCTION 3 0.0034
63 JOINT LAXITY 1 0.0033
64 WRONG SCHEDULE 3 0.0031
65 HYPERCHLORAEMIA 2 0.0031
66 ANALGESIC THERAPY 1 0.0031
67 PACKAGING DESIGN ISSUE 1 0.0030
68 NEPHROSTOMY 1 0.0030
69 BLOOD VISCOSITY DECREASED 1 0.0030
70 ILEECTOMY 1 0.0030
71 DRUG THERAPY 1 0.0029
72 ANASTOMOTIC COMPLICATION 1 0.0029
73 PRODUCT TASTE ABNORMAL 39 0.0029
74 PERINEAL PAIN 2 0.0028
75 PENIS INJURY 1 0.0028
76 ALANINE AMINOTRANSFERASE DECREASED 2 0.0028
77 MIXED ANXIETY AND DEPRESSIVE DISORDER 1 0.0027
78 LID SULCUS DEEPENED 1 0.0027
79 THERAPEUTIC PRODUCT EFFECT DELAYED 12 0.0026
80 NEUROBLASTOMA 1 0.0026
81 BLADDER PERFORATION 1 0.0026
82 OESOPHAGEAL INJURY 1 0.0026
83 CLUBBING 1 0.0025
84 ABDOMINAL LYMPHADENOPATHY 2 0.0023
85 FUNGAL FOOT INFECTION 1 0.0023
86 FEEDING INTOLERANCE 1 0.0022
87 ANASTOMOTIC ULCER 1 0.0022
88 PRODUCT AFTER TASTE 2 0.0021
89 BLOOD BICARBONATE INCREASED 1 0.0021
90 PRODUCT PACKAGING CONFUSION 5 0.0021
91 ARTERIOVENOUS FISTULA 1 0.0020
92 CORNEAL SCAR 1 0.0020
93 AUTISM 2 0.0020
94 INJECTION SITE NECROSIS 4 0.0020
95 CAPILLARY FRAGILITY 1 0.0020
96 SKIN CANDIDA 1 0.0019
97 PROCEDURAL SITE REACTION 1 0.0019
98 MEASLES 1 0.0019
99 EPHELIDES 1 0.0019
100 BLADDER DILATATION 2 0.0018
101 GASTROINTESTINAL TRACT IRRITATION 2 0.0018
102 COLON INJURY 1 0.0017
103 THERAPEUTIC PRODUCT EFFECT INCREASED 2 0.0017
104 PROTRUSION TONGUE 1 0.0017
105 LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR 1 0.0017
106 TOXIC EPIDERMAL NECROLYSIS 26 0.0017
107 ASPIRIN-EXACERBATED RESPIRATORY DISEASE 1 0.0016
108 CORNEAL PERFORATION 1 0.0016
109 PERNICIOUS ANAEMIA 1 0.0016
110 INTESTINAL ANASTOMOSIS 1 0.0016
111 SICKLE CELL ANAEMIA 1 0.0016
112 HYPERMAGNESAEMIA 1 0.0015
113 GASTROINTESTINAL MUCOSAL DISORDER 1 0.0015
114 WISDOM TEETH REMOVAL 2 0.0015
115 GINGIVAL DISCOMFORT 1 0.0015
116 ANORECTAL DISCOMFORT 8 0.0015
117 FEELING OF RELAXATION 1 0.0015
118 OPHTHALMIC MIGRAINE 1 0.0014
119 PEPTIC ULCER HAEMORRHAGE 1 0.0014
120 TONGUE DISCOMFORT 6 0.0014
121 PROTEUS INFECTION 1 0.0014
122 NASAL INJURY 1 0.0014
123 GASTROINTESTINAL SCARRING 1 0.0014
124 RESPIRATORY TRACT OEDEMA 1 0.0013
125 GASTROINTESTINAL WALL THICKENING 2 0.0013
126 HEART SOUNDS ABNORMAL 1 0.0013
127 CRITICAL ILLNESS 1 0.0013
128 METAPNEUMOVIRUS INFECTION 1 0.0013
129 POLYPECTOMY 1 0.0013
130 ENTEROCOCCAL SEPSIS 1 0.0012
131 FEAR OF FALLING 1 0.0012
132 PSEUDOMONAS TEST POSITIVE 1 0.0012
133 PERITONEAL DIALYSIS 1 0.0012
134 GASTROENTERITIS SALMONELLA 1 0.0012
135 PERIORBITAL PAIN 1 0.0012
136 APTYALISM 1 0.0012
137 TONGUE COATED 2 0.0012
138 CRANIOSYNOSTOSIS 1 0.0012
139 OESOPHAGEAL OBSTRUCTION 1 0.0012
140 PRODUCT USE COMPLAINT 18 0.0011
141 PRODUCT RECONSTITUTION QUALITY ISSUE 1 0.0011
142 BLOOD MAGNESIUM INCREASED 1 0.0011
143 NUCHAL RIGIDITY 1 0.0011
144 BONE GRAFT 1 0.0011
145 BONE CYST 1 0.0011
146 PRODUCT LABEL CONFUSION 6 0.0010
147 HYPERAEMIA 2 0.0010
148 GASTROINTESTINAL SOUNDS ABNORMAL 5 0.0010
149 BLADDER CANCER RECURRENT 1 0.0010
150 HAEMANGIOMA OF LIVER 1 0.0010
151 MUCOSAL ULCERATION 1 0.0010
152 ILEAL ULCER 1 0.0010
153 PRODUCT DIFFICULT TO SWALLOW 1 0.0010
154 EYELID PAIN 2 0.0010
155 DYSAESTHESIA 3 0.0010
156 DUODENITIS 3 0.0010
157 CHANGE OF BOWEL HABIT 2 0.0010
158 DEMYELINATING POLYNEUROPATHY 1 0.0010
159 FOREIGN BODY IN THROAT 3 0.0010
160 HYPOPERFUSION 1 0.0010
161 EAR SWELLING 2 0.0009
162 ENTEROCOCCAL BACTERAEMIA 1 0.0009
163 PHARYNGEAL ERYTHEMA 2 0.0009
164 NEUROMYOPATHY 1 0.0009
165 RETCHING 20 0.0009
166 PROCTALGIA 6 0.0009
167 HYPERPHOSPHATAEMIA 2 0.0009
168 PRODUCT NAME CONFUSION 1 0.0009
169 PRODUCT SELECTION ERROR 1 0.0009
170 PEPTIC ULCER 3 0.0009
171 HALO VISION 1 0.0009
172 CARBON DIOXIDE DECREASED 1 0.0009
173 CHEMICAL BURN 1 0.0009
174 MUCOSAL HAEMORRHAGE 1 0.0009
175 SINUS PAIN 2 0.0009
176 LIP ULCERATION 1 0.0009
177 INCISION SITE PAIN 1 0.0009
178 HYPERTENSIVE EMERGENCY 1 0.0008
179 NEPHROCALCINOSIS 1 0.0008
180 PHYSICAL PRODUCT LABEL ISSUE 1 0.0008
181 PRODUCT CONTAMINATION MICROBIAL 1 0.0008
182 BLEEDING TIME PROLONGED 1 0.0008
183 OTITIS EXTERNA 1 0.0008
184 LARGE INTESTINE INFECTION 1 0.0008
185 BLOOD UREA DECREASED 1 0.0008
186 RECTAL TENESMUS 1 0.0008
187 GASTRIC HAEMORRHAGE 9 0.0008
188 ABNORMAL UTERINE BLEEDING 2 0.0008
189 IATROGENIC INJURY 1 0.0008
190 ELECTROLYTE IMBALANCE 9 0.0008
191 RETINAL DEGENERATION 1 0.0008
192 INTERCEPTED PRODUCT SELECTION ERROR 1 0.0008
193 LIP INJURY 1 0.0008
194 PHARYNGEAL ULCERATION 1 0.0008
195 INTESTINAL DILATATION 1 0.0007
196 SKIN DEPIGMENTATION 1 0.0007
197 AGORAPHOBIA 1 0.0007
198 ORAL DISCOMFORT 10 0.0007
199 CHRONIC FATIGUE SYNDROME 1 0.0007
200 CHOKING 14 0.0007
201 THERAPEUTIC RESPONSE DELAYED 2 0.0007
202 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0007
203 AUDITORY DISORDER 1 0.0007
204 GLUTEN SENSITIVITY 1 0.0007
205 BLADDER TRANSITIONAL CELL CARCINOMA 1 0.0007
206 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
207 STRIDOR 2 0.0007
208 PRECANCEROUS SKIN LESION 1 0.0007
209 HEART VALVE REPLACEMENT 1 0.0007
210 IRON DEFICIENCY 3 0.0007
211 ANAL INCONTINENCE 6 0.0007
212 ORAL MUCOSAL EXFOLIATION 1 0.0007
213 EMBOLISM VENOUS 2 0.0007
214 AGE-RELATED MACULAR DEGENERATION 1 0.0007
215 ABDOMINAL HERNIA 3 0.0007
216 OSTEOMALACIA 1 0.0006
217 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
218 THERAPEUTIC RESPONSE CHANGED 4 0.0006
219 PHARYNGEAL PARAESTHESIA 1 0.0006
220 PULMONARY ARTERIAL PRESSURE INCREASED 1 0.0006
221 INCORRECT DRUG ADMINISTRATION DURATION 17 0.0006
222 MEDICAL PROCEDURE 1 0.0006
223 FAECES DISCOLOURED 13 0.0006
224 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
225 TONGUE ULCERATION 2 0.0006
226 CEREBELLAR INFARCTION 1 0.0006
227 ULCER HAEMORRHAGE 4 0.0006
228 ENTERITIS INFECTIOUS 1 0.0006
229 GAZE PALSY 1 0.0006
230 REGURGITATION 2 0.0006
231 FUNCTIONAL GASTROINTESTINAL DISORDER 2 0.0006
232 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
233 GASTROINTESTINAL OEDEMA 1 0.0006
234 HAEMORRHAGIC DIATHESIS 2 0.0006
235 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
236 OESOPHAGEAL SPASM 1 0.0005
237 GASTRIC ULCER HAEMORRHAGE 3 0.0005
238 COLECTOMY 3 0.0005
239 SACROILIITIS 1 0.0005
240 PARANASAL SINUS DISCOMFORT 2 0.0005
241 HYPOPROTEINAEMIA 1 0.0005
242 MYELOPATHY 1 0.0005
243 EARLY SATIETY 1 0.0005
244 GALLBLADDER INJURY 1 0.0005
245 THERAPEUTIC RESPONSE UNEXPECTED 23 0.0005
246 CARDIAC DISCOMFORT 1 0.0005
247 FOAMING AT MOUTH 1 0.0005
248 MYASTHENIA GRAVIS 4 0.0005
249 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 35 0.0005
250 ABNORMAL FAECES 4 0.0005
251 PRE-EXISTING CONDITION IMPROVED 3 0.0005
252 DEVICE MATERIAL ISSUE 1 0.0005
253 LYMPHOCYTOSIS 1 0.0005
254 MELANOCYTIC NAEVUS 2 0.0005
255 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 4 0.0005
256 PRODUCT PACKAGE ASSOCIATED INJURY 1 0.0004
257 LARGE INTESTINAL HAEMORRHAGE 1 0.0004
258 BRAIN OPERATION 1 0.0004
259 METHAEMOGLOBINAEMIA 1 0.0004
260 IMPLANT SITE INFECTION 1 0.0004
261 MENOPAUSAL SYMPTOMS 1 0.0004
262 VIRAL UPPER RESPIRATORY TRACT INFECTION 2 0.0004
263 MYOPIA 1 0.0004
264 APHAGIA 2 0.0004
265 LIQUID PRODUCT PHYSICAL ISSUE 3 0.0004
266 UTERINE LEIOMYOMA 3 0.0004
267 INCORRECT DOSAGE ADMINISTERED 2 0.0004
268 RETROPERITONEAL HAEMORRHAGE 1 0.0004
269 ABDOMINAL TENDERNESS 2 0.0004
270 CATHETER SITE HAEMORRHAGE 1 0.0004
271 COLD SWEAT 7 0.0004
272 PRODUCT SOLUBILITY ABNORMAL 2 0.0004
273 THIRST 7 0.0004
274 CANCER PAIN 1 0.0004
275 INCREASED BRONCHIAL SECRETION 1 0.0004
276 BLOOD CHLORIDE DECREASED 1 0.0004
277 SKIN NECROSIS 2 0.0004
278 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
279 BLOOD LACTIC ACID INCREASED 2 0.0004
280 THROAT IRRITATION 17 0.0004
281 PRODUCT PRESCRIBING ERROR 9 0.0004
282 ANAL ABSCESS 2 0.0004
283 FREQUENT BOWEL MOVEMENTS 10 0.0004
284 ABDOMINAL RIGIDITY 1 0.0004
285 LARGE INTESTINAL ULCER 1 0.0004
286 GASTRIC ULCER 7 0.0004
287 PRODUCT USE ISSUE 69 0.0004
288 GASTRIC PERFORATION 1 0.0004
289 BLOOD PHOSPHORUS INCREASED 1 0.0004
290 DEAFNESS UNILATERAL 2 0.0004
291 HAEMODIALYSIS 3 0.0004
292 ANAL HAEMORRHAGE 1 0.0004
293 PROCTITIS 1 0.0004
294 ABDOMINAL PAIN LOWER 9 0.0004
295 HAEMATEMESIS 9 0.0004
296 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 6 0.0004
297 FORCED EXPIRATORY VOLUME DECREASED 1 0.0004
298 SKIN HYPERPIGMENTATION 3 0.0003
299 BLOOD URIC ACID INCREASED 2 0.0003
300 ESCHERICHIA SEPSIS 1 0.0003
301 HYPOVOLAEMIA 2 0.0003
302 SPINAL OSTEOARTHRITIS 3 0.0003
303 HYPERCAPNIA 1 0.0003
304 REBOUND ACID HYPERSECRETION 1 0.0003
305 DYSCHEZIA 1 0.0003
306 RECTAL CANCER 1 0.0003
307 UROSEPSIS 3 0.0003
308 PHARYNGEAL OEDEMA 5 0.0003
309 FIBROSIS 1 0.0003
310 RESPIRATORY RATE DECREASED 1 0.0003
311 BLOOD SODIUM DECREASED 6 0.0003
312 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
313 COLITIS 12 0.0003
314 ABDOMINAL DISTENSION 33 0.0003
315 FAECAL CALPROTECTIN INCREASED 1 0.0003
316 FOREIGN BODY SENSATION IN EYES 2 0.0003
317 EXPOSURE TO TOXIC AGENT 1 0.0003
318 ENTERITIS 2 0.0003
319 TREATMENT NONCOMPLIANCE 17 0.0003
320 ATELECTASIS 3 0.0003
321 LOOSE TOOTH 1 0.0003
322 HEART RATE IRREGULAR 7 0.0003
323 LIVER ABSCESS 1 0.0003
324 FACET JOINT SYNDROME 1 0.0003
325 OEDEMA MOUTH 1 0.0003
326 INJECTION SITE INFECTION 1 0.0003
327 PRODUCT FORMULATION ISSUE 2 0.0003
328 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0003
329 ADVERSE REACTION 4 0.0003
330 METASTASES TO SPINE 1 0.0003
331 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
332 PRODUCT LABEL ISSUE 2 0.0003
333 RESPIRATION ABNORMAL 2 0.0003
334 HYPOPNOEA 1 0.0003
335 TENDERNESS 3 0.0003
336 EAR PRURITUS 1 0.0003
337 DEPRESSIVE SYMPTOM 1 0.0003
338 THERMAL BURN 2 0.0003
339 GLOSSITIS 1 0.0003
340 INCORRECT DOSE ADMINISTERED 64 0.0003
341 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
342 DISCOMFORT 17 0.0003
343 SKIN LACERATION 3 0.0003
344 LIVER TRANSPLANT 1 0.0003
345 FAECES SOFT 2 0.0003
346 BLOOD PHOSPHORUS DECREASED 1 0.0003
347 HYPOPHOSPHATAEMIA 2 0.0003
348 LIP SWELLING 9 0.0003
349 DRUG DEPENDENCE 43 0.0003
350 AUTOIMMUNE THYROIDITIS 1 0.0003
351 FACE INJURY 1 0.0003
352 BOWEL MOVEMENT IRREGULARITY 2 0.0003
353 OESOPHAGEAL DISORDER 1 0.0003
354 HYPOALBUMINAEMIA 2 0.0003
355 FAECES HARD 1 0.0003
356 APNOEA 2 0.0003
357 PROCEDURAL HAEMORRHAGE 1 0.0003
358 GASTROINTESTINAL INFLAMMATION 2 0.0003
359 FEELING COLD 7 0.0003
360 ULCER 4 0.0003
361 CEREBRAL ATROPHY 1 0.0003
362 BLEPHARITIS 1 0.0002
363 VOMITING 117 0.0002
364 FRUSTRATION TOLERANCE DECREASED 2 0.0002
365 GALLBLADDER OPERATION 1 0.0002
366 MUSCLE DISORDER 2 0.0002
367 DYSPEPSIA 24 0.0002
368 HEMIPLEGIA 2 0.0002
369 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
370 METASTATIC NEOPLASM 1 0.0002
371 HYSTERECTOMY 2 0.0002
372 HAEMORRHAGIC ANAEMIA 1 0.0002
373 PRODUCT COMMUNICATION ISSUE 2 0.0002
374 PHYSICAL DISABILITY 1 0.0002
375 RHINITIS ALLERGIC 1 0.0002
376 MENINGITIS ASEPTIC 1 0.0002
377 THROAT TIGHTNESS 6 0.0002
378 OROPHARYNGEAL DISCOMFORT 2 0.0002
379 PERIPHERAL COLDNESS 3 0.0002
380 PRODUCT USE IN UNAPPROVED INDICATION 54 0.0002
381 DYSPAREUNIA 1 0.0002
382 NERVE COMPRESSION 2 0.0002
383 HYPOKALAEMIA 10 0.0002
384 NEPHROGENIC ANAEMIA 1 0.0002
385 POLLAKIURIA 9 0.0002
386 ARTHRITIS INFECTIVE 1 0.0002
387 HYPOMAGNESAEMIA 3 0.0002
388 FEELING OF DESPAIR 1 0.0002
389 FLATULENCE 12 0.0002
390 COLITIS MICROSCOPIC 1 0.0002
391 IMPAIRED QUALITY OF LIFE 3 0.0002
392 PRESYNCOPE 5 0.0002
393 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
394 GASTRIC DISORDER 7 0.0002
395 HEPATOMEGALY 2 0.0002
396 BREATH SOUNDS ABNORMAL 1 0.0002
397 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
398 DEHYDRATION 27 0.0002
399 HYPERVOLAEMIA 1 0.0002
400 HYPERNATRAEMIA 1 0.0002
401 OVARIAN CYST 2 0.0002
402 FLUID INTAKE REDUCED 1 0.0002
403 GASTROOESOPHAGEAL REFLUX DISEASE 16 0.0002
404 HYPOTHERMIA 2 0.0002
405 DRUG ADMINISTRATION ERROR 6 0.0002
406 WRONG TECHNIQUE IN DRUG USAGE PROCESS 7 0.0002
407 FAILURE TO THRIVE 1 0.0002
408 SWOLLEN TONGUE 6 0.0002
409 UNDERDOSE 14 0.0002
410 MALABSORPTION 1 0.0002
411 PRODUCT ODOUR ABNORMAL 2 0.0002
412 TRANSFUSION 2 0.0002
413 SERUM FERRITIN INCREASED 1 0.0002
414 ABDOMINAL PAIN UPPER 39 0.0002
415 INCONTINENCE 2 0.0002
416 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
417 EYE SWELLING 7 0.0002
418 MOVEMENT DISORDER 6 0.0002
419 COMPRESSION FRACTURE 1 0.0002
420 ANAL FISSURE 1 0.0002
421 INTESTINAL RESECTION 1 0.0002
422 CHEILITIS 1 0.0002
423 NORMAL NEWBORN 1 0.0002
424 OSTEONECROSIS 6 0.0002
425 ASPIRATION 2 0.0002
426 JAW DISORDER 1 0.0002
427 ASTHENOPIA 1 0.0002
428 CHOKING SENSATION 1 0.0002
429 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2 0.0002
430 EXPIRED PRODUCT ADMINISTERED 6 0.0002
431 PRODUCT LEAKAGE 1 0.0002
432 BLOOD CALCIUM DECREASED 2 0.0002
433 CHROMATURIA 4 0.0002
434 PERIORBITAL SWELLING 1 0.0002
435 GENERALISED ERYTHEMA 1 0.0002
436 INTERNAL HAEMORRHAGE 2 0.0002
437 HYPERTONIA 1 0.0002
438 SKIN ATROPHY 1 0.0002
439 HERPES VIRUS INFECTION 1 0.0002
440 ENTEROCOLITIS 1 0.0002
441 URTICARIA 29 0.0002
442 RALES 1 0.0002
443 EYELID OEDEMA 2 0.0002
444 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
445 BLOOD PRESSURE INCREASED 26 0.0002
446 DRUG INEFFECTIVE 224 0.0002
447 HYPERCHLORHYDRIA 1 0.0002
448 HEAD DISCOMFORT 3 0.0002
449 COVID-19 PNEUMONIA 2 0.0002
450 SINUS HEADACHE 1 0.0002
451 ODYNOPHAGIA 1 0.0002
452 PROTHROMBIN TIME PROLONGED 1 0.0002
453 WRIST FRACTURE 2 0.0002
454 NAUSEA 131 0.0002
455 PLATELET COUNT ABNORMAL 1 0.0002
456 ILLNESS 17 0.0002
457 END STAGE RENAL DISEASE 3 0.0002
458 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
459 RESPIRATORY DEPRESSION 2 0.0002
460 RECTAL HAEMORRHAGE 7 0.0002
461 MENISCUS INJURY 1 0.0002
462 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
463 CONJUNCTIVITIS 3 0.0002
464 OLIGURIA 1 0.0002
465 MIDDLE INSOMNIA 3 0.0002
466 INJECTION SITE DISCOLOURATION 2 0.0002
467 PHOTOPHOBIA 3 0.0002
468 BLEPHAROSPASM 1 0.0002
469 BLOOD URINE PRESENT 3 0.0002
470 PRODUCT COMPLAINT 4 0.0002
471 FEELING JITTERY 3 0.0002
472 SKIN ULCER 4 0.0002
473 CARDIAC FLUTTER 1 0.0002
474 POOR QUALITY DRUG ADMINISTERED 1 0.0002
475 CHILLS 18 0.0002
476 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
477 PRODUCT PREPARATION ISSUE 1 0.0002
478 ANHEDONIA 4 0.0002
479 BEDRIDDEN 2 0.0002
480 GASTRITIS 4 0.0002
481 DISABILITY 3 0.0002
482 GAIT INABILITY 5 0.0001
483 QUALITY OF LIFE DECREASED 2 0.0001
484 THERAPEUTIC RESPONSE DECREASED 9 0.0001
485 COLITIS ISCHAEMIC 1 0.0001
486 SINUS CONGESTION 2 0.0001
487 TASTE DISORDER 3 0.0001
488 TACHYPNOEA 2 0.0001
489 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
490 PALLOR 4 0.0001
491 IMPAIRED GASTRIC EMPTYING 2 0.0001
492 EYE MOVEMENT DISORDER 1 0.0001
493 ONYCHOCLASIS 1 0.0001
494 RESPIRATORY DISTRESS 4 0.0001
495 DROOLING 1 0.0001
496 DEFAECATION URGENCY 1 0.0001
497 HYPOXIA 5 0.0001
498 PAPULE 1 0.0001
499 BLINDNESS UNILATERAL 2 0.0001
500 SEASONAL ALLERGY 2 0.0001
501 LYMPHADENOPATHY 5 0.0001
502 JOINT INJURY 3 0.0001
503 RETINAL HAEMORRHAGE 1 0.0001
504 BRONCHOSPASM 2 0.0001
505 DERMATITIS BULLOUS 1 0.0001
506 ABDOMINAL PAIN 32 0.0001
507 PRODUCT STORAGE ERROR 12 0.0001
508 DYSSTASIA 4 0.0001
509 ORAL DISORDER 1 0.0001
510 DIARRHOEA 88 0.0001
511 MELAENA 3 0.0001
512 SKIN HAEMORRHAGE 2 0.0001
513 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
514 BLOOD POTASSIUM DECREASED 4 0.0001
515 HYPOAESTHESIA ORAL 2 0.0001
516 PAROSMIA 1 0.0001
517 UNEVALUABLE EVENT 10 0.0001
518 ECONOMIC PROBLEM 2 0.0001
519 OSTEOPENIA 2 0.0001
520 AORTIC ANEURYSM 1 0.0001
521 DEVICE FAILURE 2 0.0001
522 ACIDOSIS 1 0.0001
523 NEPHROLITHIASIS 6 0.0001
524 LIPASE INCREASED 1 0.0001
525 DISSOCIATION 1 0.0001
526 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
527 FOOD ALLERGY 1 0.0001
528 MULTIPLE ALLERGIES 1 0.0001
529 BLOOD ALBUMIN DECREASED 1 0.0001
530 RENAL CYST 1 0.0001
531 ABSCESS 2 0.0001
532 ABDOMINAL DISCOMFORT 21 0.0001
533 LOSS OF CONSCIOUSNESS 16 0.0001
534 BLOOD DISORDER 1 0.0001
535 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
536 SENSORY LOSS 1 0.0001
537 MATERNAL EXPOSURE DURING PREGNANCY 11 0.0001
538 POST PROCEDURAL INFECTION 1 0.0001
539 SWELLING FACE 8 0.0001
540 DECUBITUS ULCER 1 0.0001
541 HICCUPS 1 0.0001
542 SECOND PRIMARY MALIGNANCY 1 0.0001
543 VIRAL INFECTION 4 0.0001
544 COAGULOPATHY 2 0.0001
545 URINARY RETENTION 4 0.0001
546 DYSPHONIA 7 0.0001
547 PALPITATIONS 14 0.0001
548 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
549 SCAR 2 0.0001
550 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
551 PRODUCT CONTAINER ISSUE 1 0.0001
552 HEADACHE 73 0.0001
553 ANAPHYLACTIC SHOCK 3 0.0001
554 CARDIAC OPERATION 1 0.0001
555 BLOOD MAGNESIUM DECREASED 1 0.0001
556 PSYCHOLOGICAL TRAUMA 1 0.0001
557 MUSCLE STRAIN 1 0.0001
558 VAGINAL HAEMORRHAGE 5 0.0001
559 HAEMORRHAGE 12 0.0001
560 MUSCLE SPASMS 21 0.0001
561 NAIL DISORDER 1 0.0001
562 INTENTIONAL PRODUCT MISUSE 10 0.0001
563 GROIN PAIN 1 0.0001
564 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
565 RESPIRATORY RATE INCREASED 1 0.0001
566 FEAR 3 0.0001
567 LOSS OF LIBIDO 1 0.0001
568 GASTROENTERITIS VIRAL 2 0.0001
569 LIMB INJURY 3 0.0001
570 DRUG EFFECT INCOMPLETE 4 0.0001
571 PELVIC PAIN 2 0.0001
572 SKIN LESION 3 0.0001
573 TINNITUS 5 0.0001
574 SKIN DISCOLOURATION 5 0.0001
575 HAEMATOCHEZIA 6 0.0001
576 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
577 TREMOR 18 0.0001
578 PROCEDURAL PAIN 3 0.0001
579 HYPERSENSITIVITY 20 0.0001
580 HAEMOPTYSIS 3 0.0001
581 HEPATIC STEATOSIS 2 0.0001
582 NECK PAIN 6 0.0001
583 DEFORMITY 1 0.0001
584 DIARRHOEA HAEMORRHAGIC 1 0.0001
585 HYPONATRAEMIA 6 0.0001
586 LACERATION 1 0.0001
587 INTESTINAL OBSTRUCTION 4 0.0001
588 ARRHYTHMIA 5 0.0001
589 DIABETES MELLITUS 8 0.0001
590 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
591 PULMONARY FIBROSIS 2 0.0001
592 ACUTE RESPIRATORY FAILURE 2 0.0001
593 HERNIA 2 0.0001
594 MALAISE 45 0.0001
595 HAEMORRHOIDS 2 0.0001
596 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
597 BODY TEMPERATURE DECREASED 1 0.0001
598 TACHYCARDIA 9 0.0001
599 CONSTIPATION 22 0.0001
600 PRESCRIBED UNDERDOSE 2 0.0001
601 SYNCOPE 10 0.0001
602 BURNING SENSATION 7 0.0001
603 BRAIN INJURY 1 0.0001
604 APHASIA 3 0.0001
605 FULL BLOOD COUNT DECREASED 2 0.0001
606 PRODUCT ADMINISTRATION ERROR 2 0.0001
607 EXTRA DOSE ADMINISTERED 4 0.0001
608 DRY THROAT 1 0.0001
609 DRUG LEVEL DECREASED 1 0.0001
610 DIZZINESS 49 0.0001
611 BLINDNESS 4 0.0001
612 BODY TEMPERATURE INCREASED 2 0.0001
613 INITIAL INSOMNIA 1 0.0001
614 EAR DISCOMFORT 1 0.0001
615 HYPERBILIRUBINAEMIA 1 0.0001
616 PETECHIAE 1 0.0001
617 DERMATITIS 2 0.0001
618 RENAL IMPAIRMENT 8 0.0001
619 INJECTION SITE DISCOMFORT 1 0.0001
620 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
621 HALLUCINATION, VISUAL 2 0.0001
622 RENAL PAIN 1 0.0001
623 MIGRAINE 9 0.0001
624 CYSTITIS 3 0.0001
625 EATING DISORDER 2 0.0001
626 DECREASED ACTIVITY 1 0.0001
627 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
628 OESOPHAGITIS 1 0.0001
629 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
630 IMPAIRED HEALING 3 0.0001
631 BLOOD GLUCOSE FLUCTUATION 1 0.0001
632 EYE DISORDER 3 0.0001
633 STAPHYLOCOCCAL INFECTION 3 0.0001
634 MEDICATION ERROR 5 0.0001
635 NERVE INJURY 1 0.0001
636 MALNUTRITION 1 0.0001
637 ORAL PAIN 2 0.0001
638 RASH PAPULAR 2 0.0001
639 SNEEZING 2 0.0001
640 OXYGEN SATURATION DECREASED 5 0.0001
641 SCAB 1 0.0001
642 FEELING ABNORMAL 21 0.0001
643 HAEMATURIA 3 0.0001
644 CHOLECYSTECTOMY 1 0.0001
645 MUSCLE TWITCHING 2 0.0001
646 SEIZURE 10 0.0001
647 METASTASES TO LUNG 1 0.0001
648 PERICARDIAL EFFUSION 2 0.0001
649 MYOCARDIAL INFARCTION 15 0.0001
650 CAESAREAN SECTION 1 0.0001
651 RENAL DISORDER 4 0.0001
652 SLEEP DISORDER 6 0.0001
653 OCULAR HYPERAEMIA 4 0.0001
654 BLOOD IRON DECREASED 1 0.0001
655 ACCIDENT 1 0.0001
656 MUSCLE RIGIDITY 1 0.0001
657 BLOOD PRESSURE FLUCTUATION 2 0.0001
658 NOCTURIA 1 0.0001
659 NEURALGIA 2 0.0001
660 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
661 CHEST PAIN 15 0.0001
662 ABNORMAL WEIGHT GAIN 1 0.0001
663 GENERALISED OEDEMA 1 0.0001
664 DYSGEUSIA 6 0.0001
665 HEART RATE INCREASED 8 0.0001
666 CYST 1 0.0001
667 APPLICATION SITE IRRITATION 1 0.0001
668 HYPOTENSION 16 0.0001
669 DYSARTHRIA 3 0.0001
670 HALLUCINATION 6 0.0001
671 POISONING 1 0.0001
672 BRAIN OEDEMA 1 0.0001
673 HYPOPHAGIA 2 0.0001
674 GASTROINTESTINAL DISORDER 7 0.0001
675 PAIN IN EXTREMITY 23 0.0001
676 HYPERHIDROSIS 10 0.0001
677 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
678 ANXIETY 22 0.0001
679 HIATUS HERNIA 1 0.0001
680 DIPLOPIA 2 0.0001
681 PLATELET COUNT INCREASED 1 0.0001
682 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
683 NODULE 1 0.0001
684 OFF LABEL USE 67 0.0001
685 MUSCULOSKELETAL PAIN 4 0.0001
686 SPEECH DISORDER 4 0.0001
687 PARAESTHESIA 12 0.0001
688 JOINT STIFFNESS 2 0.0001
689 URINARY TRACT INFECTION 13 0.0001
690 ORAL CANDIDIASIS 1 0.0001
691 ANKYLOSING SPONDYLITIS 1 0.0001
692 DERMATITIS ATOPIC 4 0.0001
693 DISORIENTATION 3 0.0001
694 HYPERTENSION 16 0.0001
695 INSOMNIA 20 0.0001
696 EYE HAEMORRHAGE 1 0.0001
697 PAIN 46 0.0001
698 SWELLING 7 0.0001
699 JOINT RANGE OF MOTION DECREASED 1 0.0001
700 BLOOD BILIRUBIN INCREASED 2 0.0001
701 PRODUCT QUALITY ISSUE 10 0.0001
702 DECREASED APPETITE 17 0.0001
703 ERYTHEMA 15 0.0001
704 DEPENDENCE 4 0.0001
705 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
706 CONTUSION 7 0.0001
707 ANAPHYLACTIC REACTION 4 0.0001
708 ATRIAL FIBRILLATION 7 0.0001
709 CARDIO-RESPIRATORY ARREST 3 0.0001
710 MASS 1 0.0001
711 CARPAL TUNNEL SYNDROME 1 0.0001
712 BLISTER 4 0.0001
713 DIALYSIS 1 0.0001
714 RED BLOOD CELL COUNT DECREASED 2 0.0001
715 PARAESTHESIA ORAL 1 0.0001
716 HYPOKINESIA 1 0.0001
717 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
718 FLUID OVERLOAD 1 0.0001
719 APATHY 1 0.0001
720 NASAL CONGESTION 4 0.0001
721 PULMONARY MASS 1 0.0001
722 COLITIS ULCERATIVE 3 0.0001
723 HYPOAESTHESIA 10 0.0001
724 ADVERSE DRUG REACTION 6 0.0001
725 THERAPY NON-RESPONDER 3 0.0001
726 CHRONIC KIDNEY DISEASE 5 0.0001
727 DRUG DISPENSING ERROR 1 0.0001
728 HIP ARTHROPLASTY 1 0.0001
729 MUSCULOSKELETAL CHEST PAIN 1 0.0001
730 COGNITIVE DISORDER 3 0.0001
731 DYSPNOEA 36 0.0001
732 CYANOSIS 1 0.0001
733 RESPIRATORY TRACT CONGESTION 1 0.0001
734 HALLUCINATION, AUDITORY 1 0.0001
735 METABOLIC ACIDOSIS 2 0.0001
736 WEIGHT INCREASED 14 0.0001
737 MUSCLE TIGHTNESS 1 0.0001
738 AMNESIA 4 0.0001
739 BLOOD CREATININE INCREASED 4 0.0001
740 CHOLELITHIASIS 2 0.0001
741 MULTIPLE FRACTURES 1 0.0001
742 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
743 SKIN DISORDER 2 0.0001
744 BLOOD UREA INCREASED 1 0.0001
745 CELLULITIS 3 0.0001
746 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
747 FLUID RETENTION 3 0.0001
748 PERIPHERAL SWELLING 9 0.0001
749 BLOOD GLUCOSE INCREASED 11 0.0001
750 INFLAMMATION 3 0.0001
751 MUSCULOSKELETAL DISCOMFORT 1 0.0001
752 DEVICE USE ERROR 2 0.0001
753 NEOPLASM PROGRESSION 2 0.0001
754 ORTHOSTATIC HYPOTENSION 1 0.0001
755 NERVOUSNESS 3 0.0001
756 LOCAL SWELLING 1 0.0001
757 RASH MACULAR 2 0.0001
758 INJURY 4 0.0001
759 BRADYCARDIA 3 0.0001
760 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
761 GALLBLADDER DISORDER 1 0.0001
762 RASH PRURITIC 3 0.0001
763 LEUKOCYTOSIS 1 0.0001
764 BONE DISORDER 1 0.0001
765 SOMNOLENCE 11 0.0001
766 DYSURIA 2 0.0001
767 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
768 BLOOD GLUCOSE ABNORMAL 1 0.0001
769 BRONCHITIS 4 0.0001
770 OROPHARYNGEAL PAIN 5 0.0001
771 BACTERIAL INFECTION 1 0.0001
772 HEPATIC FUNCTION ABNORMAL 2 0.0001
773 EPISTAXIS 4 0.0001
774 EYE PAIN 3 0.0001
775 HOT FLUSH 4 0.0001
776 HYPOCALCAEMIA 1 0.0001
777 MUSCULAR WEAKNESS 6 0.0001
778 DYSPHAGIA 5 0.0001
779 MUSCULOSKELETAL DISORDER 1 0.0001
780 INCREASED APPETITE 1 0.0001
781 CHOLESTASIS 1 0.0001
782 POST PROCEDURAL COMPLICATION 1 0.0001
783 LOWER LIMB FRACTURE 1 0.0001
784 GLAUCOMA 1 0.0001
785 DRUG INTOLERANCE 5 0.0001
786 ERUCTATION 1 0.0001
787 PRESCRIBED OVERDOSE 1 0.0001
788 BACK PAIN 12 0.0001
789 ORAL HERPES 1 0.0001
790 BONE PAIN 3 0.0001
791 SKIN FISSURES 1 0.0001
792 VISION BLURRED 7 0.0001
793 RASH 22 0.0001
794 HAEMATOCRIT DECREASED 1 0.0001
795 BLOOD PRESSURE ABNORMAL 1 0.0001
796 WEIGHT DECREASED 14 0.0001
797 CARDIAC FAILURE 4 0.0000
798 THROMBOSIS 4 0.0000
799 PRODUCT PHYSICAL ISSUE 1 0.0000
800 EMOTIONAL DISTRESS 6 0.0000
801 PRURITUS 19 0.0000
802 ILL-DEFINED DISORDER 3 0.0000
803 BONE MARROW FAILURE 1 0.0000
804 FEELING HOT 3 0.0000
805 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
806 CHEST DISCOMFORT 5 0.0000
807 LUNG NEOPLASM MALIGNANT 2 0.0000
808 RIB FRACTURE 1 0.0000
809 PERITONITIS 1 0.0000
810 PULMONARY HYPERTENSION 1 0.0000
811 ASTHENIA 18 0.0000
812 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
813 INTENTIONAL DRUG MISUSE 1 0.0000
814 MOUTH ULCERATION 1 0.0000
815 SKIN EXFOLIATION 4 0.0000
816 RENAL FAILURE ACUTE 2 0.0000
817 IMPAIRED WORK ABILITY 1 0.0000
818 IRRITABLE BOWEL SYNDROME 1 0.0000
819 LIVER FUNCTION TEST INCREASED 1 0.0000
820 POOR QUALITY SLEEP 1 0.0000
821 RHINORRHOEA 3 0.0000
822 COUGH 13 0.0000
823 PRURITUS GENERALISED 1 0.0000
824 DEEP VEIN THROMBOSIS 3 0.0000
825 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
826 SEPTIC SHOCK 2 0.0000
827 MENTAL DISORDER 2 0.0000
828 HOSPITALISATION 7 0.0000
829 APPLICATION SITE PAIN 1 0.0000
830 RENAL FAILURE 6 0.0000
831 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
832 LIVER DISORDER 2 0.0000
833 PULMONARY OEDEMA 2 0.0000
834 ASTHMA 5 0.0000
835 HEPATIC ENZYME INCREASED 3 0.0000
836 SUICIDAL IDEATION 4 0.0000
837 SHOCK 1 0.0000
838 NASOPHARYNGITIS 8 0.0000
839 PYREXIA 15 0.0000
840 CONFUSIONAL STATE 7 0.0000
841 PNEUMONIA 14 0.0000
842 COMA 2 0.0000
843 RASH ERYTHEMATOUS 2 0.0000
844 GAIT DISTURBANCE 8 0.0000
845 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
846 JOINT SWELLING 5 0.0000
847 CEREBROVASCULAR ACCIDENT 7 0.0000
848 MENTAL IMPAIRMENT 1 0.0000
849 FIBROMYALGIA 1 0.0000
850 CEREBRAL INFARCTION 1 0.0000
851 AGITATION 3 0.0000
852 LUNG DISORDER 2 0.0000
853 INJECTION SITE URTICARIA 1 0.0000
854 ALOPECIA 8 0.0000
855 ENCEPHALOPATHY 1 0.0000
856 VISUAL IMPAIRMENT 5 0.0000
857 AGEUSIA 1 0.0000
858 GASTRIC CANCER 1 0.0000
859 FLUSHING 4 0.0000
860 INJECTION SITE SWELLING 3 0.0000
861 ERECTILE DYSFUNCTION 1 0.0000
862 RASH GENERALISED 1 0.0000
863 HAEMATOMA 1 0.0000
864 DEAFNESS 1 0.0000
865 ECZEMA 2 0.0000
866 MUCOSAL INFLAMMATION 1 0.0000
867 SEDATION 1 0.0000
868 EAR INFECTION 1 0.0000
869 DRY SKIN 5 0.0000
870 FATIGUE 29 0.0000
871 PAIN OF SKIN 1 0.0000
872 OEDEMA 2 0.0000
873 ANAEMIA 7 0.0000
874 CARDIAC ARREST 3 0.0000
875 RESPIRATORY ARREST 1 0.0000
876 ABNORMAL DREAMS 1 0.0000
877 CONDITION AGGRAVATED 11 0.0000
878 ARTHRALGIA 15 0.0000
879 MENTAL STATUS CHANGES 1 0.0000
880 INFLUENZA 4 0.0000
881 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
882 MYALGIA 6 0.0000
883 DEPRESSION 8 0.0000
884 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
885 CONVULSION 2 0.0000
886 ANGINA PECTORIS 1 0.0000
887 HERPES ZOSTER 2 0.0000
888 LETHARGY 2 0.0000
889 PRODUCT SUBSTITUTION ISSUE 2 0.0000
890 PANCREATIC CARCINOMA 1 0.0000
891 LIVER FUNCTION TEST ABNORMAL 1 0.0000
892 ASCITES 1 0.0000
893 PRODUCT DOSE OMISSION ISSUE 10 0.0000
894 BLADDER CANCER 2 0.0000
895 LABORATORY TEST ABNORMAL 1 0.0000
896 PSYCHOTIC DISORDER 1 0.0000
897 WHEEZING 2 0.0000
898 RENAL INJURY 1 0.0000
899 CATARACT 2 0.0000
900 IRRITABILITY 2 0.0000
901 HEPATIC FAILURE 1 0.0000
902 LACRIMATION INCREASED 1 0.0000
903 CORONARY ARTERY DISEASE 1 0.0000
904 STOMATITIS 2 0.0000
905 OEDEMA PERIPHERAL 4 0.0000
906 VERTIGO 2 0.0000
907 EPILEPSY 1 0.0000
908 EMOTIONAL DISORDER 1 0.0000
909 LIMB DISCOMFORT 1 0.0000
910 EXPOSURE DURING PREGNANCY 2 0.0000
911 CARDIAC DISORDER 3 0.0000
912 HEAD INJURY 1 0.0000
913 PULMONARY EMBOLISM 3 0.0000
914 HYPOTHYROIDISM 1 0.0000
915 HIP FRACTURE 1 0.0000
916 PSORIASIS 4 0.0000
917 INFUSION RELATED REACTION 2 0.0000
918 BLOOD PRESSURE DECREASED 2 0.0000
919 FALL 10 0.0000
920 NEOPLASM MALIGNANT 2 0.0000
921 EYE PRURITUS 1 0.0000
922 SINUSITIS 3 0.0000
923 HAEMOGLOBIN DECREASED 3 0.0000
924 DEATH 25 0.0000
925 DELIRIUM 1 0.0000
926 HYPERKALAEMIA 1 0.0000
927 COVID-19 5 0.0000
928 HEART RATE DECREASED 1 0.0000
929 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
930 THERAPY INTERRUPTED 2 0.0000
931 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
932 OVERDOSE 6 0.0000
933 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
934 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
935 CRYING 1 0.0000
936 C-REACTIVE PROTEIN INCREASED 1 0.0000
937 HYPERGLYCAEMIA 1 0.0000
938 PANIC ATTACK 1 0.0000
939 RESTLESSNESS 1 0.0000
940 INJECTION SITE MASS 1 0.0000
941 SEPSIS 3 0.0000
942 DYSPNOEA EXERTIONAL 1 0.0000
943 ACUTE KIDNEY INJURY 4 0.0000
944 DRUG DOSE OMISSION BY DEVICE 2 0.0000
945 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
946 PROSTATE CANCER 2 0.0000
947 DRY MOUTH 2 0.0000
948 PSORIATIC ARTHROPATHY 1 0.0000
949 DEVICE BREAKAGE 1 0.0000
950 DRUG DOSE OMISSION 4 0.0000
951 DRUG ABUSE 2 0.0000
952 TOXICITY TO VARIOUS AGENTS 4 0.0000
953 OSTEOARTHRITIS 1 0.0000
954 BALANCE DISORDER 2 0.0000
955 DEVICE DISLOCATION 1 0.0000
956 INJECTION SITE PAIN 7 0.0000
957 DRUG WITHDRAWAL SYNDROME 2 0.0000
958 ANGIOEDEMA 1 0.0000
959 MEMORY IMPAIRMENT 3 0.0000
960 SKIN IRRITATION 1 0.0000
961 ADVERSE EVENT 2 0.0000
962 BLOOD CHOLESTEROL INCREASED 1 0.0000
963 DISEASE RECURRENCE 1 0.0000
964 RENAL CANCER 1 0.0000
965 PRODUCTIVE COUGH 1 0.0000
966 BLOOD GLUCOSE DECREASED 1 0.0000
967 INFECTION 3 0.0000
968 DRY EYE 1 0.0000
969 AGGRESSION 1 0.0000
970 DEPRESSED MOOD 1 0.0000
971 DRUG INTERACTION 3 0.0000
972 DRUG EFFECT DECREASED 1 0.0000
973 EYE IRRITATION 1 0.0000
974 NO ADVERSE EVENT 3 0.0000
975 PLEURAL EFFUSION 1 0.0000
976 INJECTION SITE ERYTHEMA 2 0.0000
977 INTENTIONAL OVERDOSE 1 0.0000
978 MOBILITY DECREASED 1 0.0000
979 RESPIRATORY FAILURE 1 0.0000
980 INJECTION SITE BRUISING 1 0.0000
981 CARDIAC FAILURE CONGESTIVE 1 0.0000
982 INFLUENZA LIKE ILLNESS 1 0.0000
983 COMPLETED SUICIDE 1 0.0000
984 MUSCULOSKELETAL STIFFNESS 1 0.0000
985 DEVICE ISSUE 1 0.0000
986 BREAST CANCER 1 0.0000
987 NEUROPATHY PERIPHERAL 1 0.0000
988 DISEASE PROGRESSION 1 0.0000
989 NEUTROPENIA 1 0.0000